CSL Behring Lengnau AG
- Sector unverified
- Rank 249 / 334
CSL Behring Lengnau AG is recorded by Swissmedic as the authorisation holder for 2 human medicines, which places it 249 of 334 authorisation holders. Its portfolio is mostly in the Biotechnologika category (100 % of its authorisations). We hold no research of our own on this company's sector or business model, so we assign it to none.
Sector unverified: the Swissmedic list carries no sector field and we have not researched this company.
Key facts
| Sector | Not available |
|---|---|
| City | Not available |
| Canton | Not available |
| Authorisation holder | Yes |
| Medicines | 2 |
| Founded | Not available |
| Employees | Not available |
| Parent group | Not available |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
CSL Behring Lengnau AG is recorded by Swissmedic as the authorisation holder for 2 human medicines. The table shows 2 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
2 of 2 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Afstyla 250 IE | 66030 | B | B02BD02 | 2017-04-07 |
| Idelvion 250 IU | 65743 | B | B02BD04 | 2016-08-30 |
Frequently asked questions
How many medicines does CSL Behring Lengnau AG have authorised in Switzerland?
CSL Behring Lengnau AG is recorded by Swissmedic as the authorisation holder for 2 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is CSL Behring Lengnau AG based?
We have no confirmed Swiss address for CSL Behring Lengnau AG. We add it as soon as the commercial register or the company confirms it.
Is CSL Behring Lengnau AG a Swissmedic authorisation holder?
Yes. CSL Behring Lengnau AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.